IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Ovarian Carcinoma
M.D. Anderson Cancer Centermonoclonal_antibodyPhase 2Active
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 51/ 100
- Competitive Position
- 81/ 100
Competitive context
59 Active assets in the Ovarian Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Palbociclib University Medical Center Groningen | Phase 4 | BB |
Docetaxel Case Comprehensive Cancer Center | Phase 3 | BB |
Eloxatin Moscow Regional Oncological Dispensary | Phase 3 | BB |
su011248 University Medical Center Groningen | Phase 4 | B |
ETOPOSIDE Fudan University | Phase 2 | B |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →